ALPHA-O PEPTIDES
Alpha-O Peptides AG (“AOP”) is a Swiss nano-biotechnology company focusing on the development of potent vaccines based on repetitive antigen display technology using their proprietary and patented self-assembling protein nanoparticles (SAPNs). AOP’s most advanced vaccine has demonstrated complete protection against malaria infection in an animal model. The National Institutes of Health (NIH) and the U.S. Military Infectious Disease Research Program have both supported this project. In add... ition, a grant from the US Department of Defense was awarded in 2014 to run a phase I/IIa clinical trial at the Walter Reed Army Institute of Research (WRAIR). In 2011, in collaboration with the University of Connecticut and the Kantonsspital St. Gallen, AOP received a 5-year NIH-NIDA award for the development of a nicotine vaccine from preclinical research into clinical trials phase I, which is currently also in GMP production. AOP has further initiated pre-clinical and basic research projects of several other programs targeting cancer and several other infectious diseases.
ALPHA-O PEPTIDES
Industry:
Biotechnology Clinical Trials Nanotechnology
Founded:
2003-01-01
Address:
Riehen, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.aopeptides.com
Status:
Active
Contact:
41 61 641 2201
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Google Cloud QUIC Wix
Similar Organizations
IcanoMAB
IcanoMAB is a biotech company focusing on pre-clinical and clinical development for the treatment of cancer and other related diseases.
Official Site Inspections
http://www.aopeptides.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
